MMR/MSI Phenotypes in Prediction of Tumor Vaccine Benefit for Gliomas
Clinical trial NCT06043232 · UNKNOWN
Trial details
- NCT number
- NCT06043232
- Sponsor
- Huashan Hospital
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2023-09-01
- Primary completion
- 2026-03-01
- Enrollment
- 360
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.